Publications (First author/Corresponding author)
2024
79. Wu S, Zhu L, Ni S, Zhao X, Yan M, Zhong Y, Kusuma K, Liang Y, Bao K, Qu K, Qin X, Zhang K, Deng W,* Sun D,* Wu W,* Hemoglobin integrated red blood cell membrane-coated metal-organic framework nano-platform for improving the self-adaptive blood glucose management. Nano Research, 2024, Accepted. (IF:9.5)
78. Zhao X, Wu S, Ni S, Zhong Y, Qin X, Zhang K, Qu K,* Zhu L,* Wu W,* Tannic acid-based biomimetic nanomedicine with pathological reactive oxygen species responsive cargo release for relieving inflammation in rheumatoid arthritis. ACS Applied Materials & Interfaces, 2024, 16 (44): 59789-59802. (IF:8.3)
77. Mou N,† Duan X,† Qu K, Chen Q, He Z, Cao Y, Zhang K, Qin X, Zhu L, Han Z, Li C,* Zhong Y,* Wu W,* Macrophage Membrane Spontaneously Encapsulated Cyclodextrin-Based Nanomedicines for Improving Lipid Metabolism and Inflammation in Atherosclerosis. ACS Applied Materials & Interfaces, 2024, 16 (37): 49660-49672. (IF:8.3)
76. Cao Y, Han Z, Zhu L, He Z, Mou N, Duan X, Chen Q, Qin X,* Zhang K, Qu K, Zhong Y,* Wu W,* Red blood cell membrane spontaneously coated nano-prodrug based on phosphatidylserine for anti-atherosclerosis applications. ACS Applied Materials & Interfaces, 2024, 16 (35): 46578-46589. (IF:8.3)
75. 吴伟, 覃弦, 瞿凯, 张坤, 朱力, 钟元, 红细胞膜自发定向包被ROS响应的纳米前药及其应用[P]. 发明专利, ZL202211361359.2.
74. Duan X, Yang X, Mou N, Cao Y, He Z, Zhu L, Zhong Y, Zhang K, Qu K, Qin X, Chen Q,* Luo Y,* Wu W,* Reactive oxygen species-triggered carbon dots-based biomimetic nanotheranostic agents for atherosclerosis management. Advanced Functional Materials, 2024, 34(48): 2405629. (IF:18.5, Nature Index)
73. Ni S, Zhang K, Zhao X, Wu S, Yan M, Sun D,* Zhu L,* Wu W,* Phenylboronic acid functionalized dextran loading curcumin as nano-therapeutics for promoting the bacteria-infected diabetic wound healing. International Journal of Biological Macromolecules, 2024, 273(1): 133062. (IF:7.7)
72. Zhu L, Zhong Y, Yan M, Ni S, Zhao X, Wu S, Wang G, Zhang K, Chi Q, Qin X, Li C,* Huang X,* Wu W,* Macrophage membrane-encapsulated dopamine-modified poly-cyclodextrin multifunctional biomimetic nanoparticles for atherosclerosis therapy. ACS Applied Materials & Interfaces, 2024, 16(25): 32027-32044 (IF:8.3)
71. Qin X,† Zhu L,† An X, Zhang C, Li J, Yan F, Zhang W, Qu K,* Zhang K,* Wu W,* Wu G,* Hybrid Cell Membranes Camouflaged Copper-Loaded Nano-Prodrug for Tumor Angiogenesis Inhibition and Cell Cuproptosis. Chemical Engineering Journal, 2024, 493: 152323. (IF:13.3)
70. He Z, Chen Q, Duan X, Zhong Y, Zhu L, Mou N, Yang X, Cao Y, Han Z, He H, Wu S, Wang G, Qin X, Qu K, Zhang K,* Liu J,* Wu W,* Reactive Oxygen Species-Responsive Nano-platform with Dual-Targeting and Fluorescent Lipid-Specific Imaging Capabilities for the management of Atherosclerotic Plaques. Acta Biomaterialia, 2024, 181: 375-390. (IF:9.4)
69. Qu K,† Zhong Y,† Zhu L,† Mou N, Cao Y, Liu J, Wu S, Yan M, Yan F, Li J, Zhang C, Wu G, Kun Zhang,* Qin X,* Wu W,* A Macrophage Membrane-Functionalized, Reactive Oxygen Species-Activatable Nanoprodrug to Alleviate Inflammation and Improve the Lipid Metabolism for Atherosclerosis Management. Advanced Healthcare Materials, 2024, 13(26): 2401113. (IF:10)
68. Ma Y,† Yi J,† Ruan J,† Ma J, Yang Q, Zhang K, Zhang M, Zeng G, Jin L, Huang X, Li J,* Yang H,* Wu W,* Sun D,* Engineered Cell Membrane-Coated Nanoparticles: New Strategies in Glioma Targeted Therapy and Immune Modulation. Advanced Healthcare Materials, 2024, 13 (20): 2400514. (IF:10)
67. Chen J,† Luo A,† Xu M, Zhao Y, Xu Z, Yu S, Zhu L,* Wu W,* Yang D,* The application of phenylboronic acid pinacol ester functionalized ROS-responsive multifunctional nanoparticles in the treatment of Periodontitis. Journal of Nanobiotechnology, 2024, 22: 181.(IF:10.6)
66. 吴伟, 张坤, 瞿凯, 覃弦, 朱力, 钟元, 前药封装的工程化益生菌及其制备方法与应用[P]. 发明专利, ZL202211403974.5.
65. Qin X,† Zhu L,† Zhong Y, Wang Y, Luo X, Li J. Yan F, Wu G, Qiu J, Wang G, Qu K,* Zhang K,* Wu W,* Universal cell membrane camouflaged nano-prodrugs with right-side-out orientation adapting for positive pathological vascular remodeling in atherosclerosis. Chemical Science, 2024, 15: 7524-7544. (IF:7.6, Nature Index)
64. Qu L,† Li Y,† Liu F,† Fang Y, He J, Ma J, Xu T, Wang L, Lei P, Dong H, Jin L, Yang Q,* Wu W,* Sun D,* Microbiota-Gut-Brain Axis Dysregulation in Alzheimer's Disease: Multi-Pathway Effects and Therapeutic Potential. Aging and Disease, 2024, 15 (3): 1108-1131. (IF:7, ESI)
63. Wu S,† Zhu L,† Ni S, Zhong Y, Qu K, Qin X, Zhang K, Wang G, Sun D,* Deng W,* Wu W,* Hyaluronic acid-decorated curcumin-based coordination nanomedicine for enhancing the infected diabetic wound healing. International Journal of Biological Macromolecules, 2024, 263(1): 130249. (IF:7.7)
62. Huang X,* Mu N, Ding Y, Huang R, Wu W,* Li L,* Chen T,* Tumor microenvironment targeting for glioblastoma multiforme treatment via hybrid cell membrane coating supramolecular micelles. Journal of Controlled Release, 2024, 366: 194-203. (IF:10.5, ESI)
61. Li H, Zhu L, Zhang Y, Yang L, Wu W,* Yang D,* Biomimetic Nanotherapeutics for Homotypic-Targeting Photothermal/Chemotherapy of Oral Cancer. Journal of Controlled Release, 2024, 366: 28-43. (IF:10.5)
60. Ma J, Fang Y, Yu H, Yi J, Ma Y, Lei P, Yang Q, Jin L, Wu W,* Li H,* Sun D,* Recent advances in living algae seeding wound dressing: focusing on diabetic chronic wound healing. Advanced Functional Materials, 2024, 34(2): 2308387. (IF:18.5, Nature Index)
59. Chen Q, Duan X, Yu Y, Ni R, Song G, Yang X, Zhu L, Zhong Y, Zhang K,* Qu K,* Yang D,* Qin X,* Wu W,* Target functionalized carbon dot nanozymes with dual-model photoacoustic and fluorescence imaging for visual therapy in atherosclerosis. Advanced Science, 2024, 11(6): 2307441. (IF:14.3)
2023
58. Yan M,† Liang W,† Du L, Guo R, Cao Y, Ni S, Zhong Y, Zhang K, Qu K, Qin X, Chen L,* Wu W,* Metronidazole-loaded polydopamine nanomedicine with antioxidant and antibacterial bioactivity for periodontitis. Nanomedicine, 2023, 18(29): 2143-2157. (IF:4.7)
57. Zhong Y,† Maruf A,† Qu K, Milewska M, Wandzik I*, Mou N, Cao Y, Wu W,* Nanogels with covalently bound and releasable trehalose for autophagy stimulation in atherosclerosis. Journal of Nanobiotechnology, 2023, 21: 472.(IF:10.6)
56. 吴伟, 刘博妍, 钟元, 焉梦, 吴帅, 朱力, 抑制损伤血管内膜增生的纳米药物及其应用[P]. 发明专利, ZL202111171093.0.
55. Liu J, He Z, Zhong Y, Zhu L, Yan M, Mou N, Qu K, Qin X, Wang G, Zhang K,* Yang W,* Wu W,* Reactive Oxygen Species-Responsive Sequentially Targeted AIE Fluorescent Probe for Precisely Identifying the Atherosclerotic Plaques. ACS Applied Materials & Interfaces, 2023, 15 (40): 47381-47393. (IF:8.3)
54. Zhu L, Li H, Li J, Zhong Y, Wu S, Yan M, Ni S, Zhang K, Wang G, Qu K,* Yang D,* Qin X,* Wu W,* Biomimetic nanoparticles to enhance the reverse cholesterol transport for selectively inhibiting development into foam cell in atherosclerosis. Journal of Nanobiotechnology, 2023, 21: 307. (IF:10.2)
53. Lei P, Yu H, Ma J, Du J, Fang Y, Yang Q, Zhang K, Luo L, Jin L,* Wu W,* Sun D,* Cell membrane nanomaterials composed of phospholipids and glycoproteins for drug delivery in inflammatory bowel disease: A review. International Journal of Biological Macromolecules, 2023, 249: 126000. (IF:7.7)
52. Ye J; Liang W; Wu L; Guo R; Wu W,* Yang D,* Chen L,* Antimicrobial effect of Streptococcus salivarius outer membrane-coated nanocomplexes against Candida albicans and oral candidiasis. Materials & Design, 2023, 233: 112177. (IF:7.6)
51. Chen H, Lei P, Ji H, Ma J, Fang Y, Yu H, Du J, Qu L, Yang Q, Wu W,* Jin L,* Sun D,* Escherichia coli Nissle 1917 ghosts alleviate inflammatory bowel disease in zebrafish. Life Sciences, 2023, 329: 121956. (IF:5.2)
50. Wang L, Liu F, Fang Y, Ma J, Wang J, Qu L, Yang Q, Wu W,* Jin L,* Sun D,* Advances in Zebrafish as a Comprehensive Model of Mental Disorders. Depression and Anxiety, 2023, 2023: 6663141. (IF:4.7)
49. Qu L,† Liu F,† Fang Y,† Wang L, Chen H, Yang Q, Dong H, Jin L,* Wu W,* Sun D,* Improvement in Zebrafish with Diabetes and Alzheimer's Disease Treated with Pasteurized Akkermansia muciniphila. Microbiology Spectrum, 2023, 11(3): . (IF:3.7)
48. Sun P, Jiao J, Wang X, Chen L, Chen Z, Zhang K, Qu K, Qin X, Yang Z,* Zhong J,* Wu W,* Nanomedicine hybrid and catechol functionalized chitosan as pH-responsive multi-function hydrogel to efficiently promote infection wound healing. International Journal of Biological Macromolecules, 2023, 238: 124106. (IF:7.7)
47. Lin B,† Ma J,† Fang Y,† Lei P, Wang L, Qu L, Wu W,* Jin L,* Sun D,* Advances in zebrafish for diabetes mellitus with wound model. Bioengineering, 2023, 10(3): 330. (IF:3.8)
46. Chen H,† Lei P,† Ji H,† Yang Q, Peng B, Ma J, Fang Y, Qu L, Li H, Wu W,* Jin L,* Sun D,* Advances in Escherichia coli Nissle 1917 as a customizable drug delivery system for disease treatment and diagnosis strategies. Materials Today Bio, 2023, 18: 100543. (IF:8.7, ESI)
45. Qin X,† Zhu L,† Zhong Y, Wang Y, Wu G, Qiu J, Wang G, Qu K,* Zhang K,* Wu W,* Spontaneously Right-Side-Out-Orientated Coupling-Driven ROS-Sensitive Nanoparticles on Cell Membrane Inner Leaflet for Efficient Renovation in Vascular Endothelial Injury. Advanced Science, 2023, 10(6): 220509. (IF:14.3)
44. Zhang K,† Zhu L,† Zhong Y, Xu L, Lang C, Chen J, Yan F, Li J, Qiu J, Chen Y, Sun D, Wang G, Qu K,* Qin X,* Wu W,* Prodrug Integrated Envelope on Probiotics to Enhance Target Therapy for Ulcerative Colitis. Advanced Science, 2023, 10(4): 2205422. (IF:14.3)
43. 曹钰, 牟年莲, 朱力, 王溢, 王贵学,* 吴伟,* 红细胞膜仿生纳米药物载体在动脉粥样硬化治疗中的应用研究进展. 中国动脉硬化杂志, 2023, 1: 1-8.
42. Li J,† Zhu L,† Wu S, Wang G, Chen Y*, Wu W,* MPEG-phenylboronic acid modified doxorubicin as the efficient pathological pH-responsive nanoplatform for potential anti-cancer delivery. Macromolecular Research, 2023, 31: 181-191. (IF:2.8)
2022
41. Yan M, Zhu L, Wu S, Cao Y, Mou N, Chi Q, Wang G, Yuan Zhong*, Wu W,* ROS responsive polydopamine nanoparticles to relieve oxidative stress and inflammation for ameliorating acute inflammatory bowel. Biomaterials Advances (Materials Science & Engineering C), 2022, 142: 213126. (IF:5.5)
40. Weng L,† Wu L,† Guo R,† Ye J, Liang W, Wu W,* Chen L,* Yang D,* Lactobacillus cell envelope-coated nanoparticles for antibiotic delivery against cariogenic biofilm and dental caries. Journal of Nanobiotechnology, 2022, 20: 356. (IF:10.6)
39. Obaid EAMS,† Wu S,† Zhong Y, Yan M, Zhu L, Li B, Wang Y*, Wu W,* Wang G,* pH-responsive hyaluronic acid-enveloped ZIF-8 nanoparticles for anti-atherosclerosis therapy. Biomaterials Science, 2022, 10: 4837-4847. (IF:5.8)
38. Wang L,† Ma J,† Wu W,† Fang Y, Liu F, Yang Q, Hu X, Gu X, He Z, Sun D,* Jin L,* Zhang X,* Effect of aerobic exercise as a treatment on type 2 diabetes mellitus with depression-like behavior zebrafish. Life Sciences, 2022, 300: 120578. (IF:5.2)
37. Zhong Y, Qu K, Yan W, Zhang K, Qin X, Wang Y, Yan M, Wu S, Zhu L, Obaid E, Wang G, Wu W,* Overexpressed VLA-4 on Endothelial Cell Membrane Camouflaging the Pathological Reactive Oxygen Species Responsive Prodrug to Enhance Target Therapy for Atherosclerosis. Chemical Engineering Journal, 2022, 442: 136198. (IF:13.3)
36. Zhu L, Zhong Y, Wu S, Yan M, Cao Y, Mou N, Wang G, Sun D,* Wu W,* Cell membrane camouflaged biomimetic nanoparticles: Focusing on tumor theranostics. Materials Today Bio, 2022, 14: 100228. (IF:8.7)
35. Andy W, Wang Y, Tang D, Zhong Y, Liu B, Yan M, Qiu J, Wu W,* Wang G,* Study of Lovastatin and L-Arginine Co-loaded PLGA Nanomedicine for Enhancing Nitric Oxide Production and eNOS Expression. Journal of Materials Chemistry B, 2022, 10: 607-624. (IF:6.1)
2021
34. Liu B, Yan W, Luo L, Wu S, Wang Y, Zhong Y, Tang D, Maruf A, Yan M, Zhang K, Qin X, Qu K, Wu W,* Wang G, Macrophage membrane camouflaged reactive oxygen species responsive nanomedicine for efficiently inhibiting the vascular intimal hyperplasia. Journal of Nanobiotechnology, 2021, 19: 374. (IF:10.6)
33. Ji H,† Peng R,†, Jin L, Ma J, Yang Q, Sun D,* Wu W.*. Recent advances in ROS-sensitive nano-formulations for atherosclerosis. Pharmaceutics, 2021, 13(9): 1452.(IF:4.9)
32. Zhong Y, Qin X, Wang Y, Qu K, Luo L, Zhang K, Liu B, Obaid E, Wu W,* Wang G,* “Plug and Play” Functionalized Erythrocyte Nanoplatform for Target Atherosclerosis Management. ACS Applied Materials & Interfaces, 2021, 13(29): 33862-33873. (IF:8.3)
31. Luo L, Zang G, Liu B, Qin X, Zhang Y, Chen Y, Zhang H, Wu W,* Wang G,* Bioengineering CXCR4-overexpressing cell membrane functionalized ROS-responsive nanotherapeutics for targeting cerebral ischemia-reperfusion injury. Theranostics, 2021, 11(16): 8043-8056.(IF:12.4, Back Cover)
30. Tang D,† Wang Y,† Wijaya A, Liu B, Maruf A, Wang J, Xu J, Liao X, Wu W,* Wang G,* ROS-responsive biomimetic nanoparticles for potential application in targeted anti-atherosclerosis. Regenerative Biomaterials, 2021, 8(4): rbab033. (IF:5.6)
29. Chen L, Chen W, Yu Y, Yang J, Jiang Q, Wu W,* Yang D,* Effect of chlorhexidine-loaded poly(amido amine) dendrimer on matrix metalloproteinase activities and remineralization in etched human dentin in vitro. Journal of the Mechanical Behavior of Biomedical Materials, 2021, 121: 104625. (IF:3.3)
28. Wang Y,† Zhang K,† Li T, Maruf A, Qin X, Luo L, Zhong Y, Qiu J, McGinty S, Pontrelli G, Liao X,* Wu W,* Wang G,* Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications. Theranostics, 2021, 11(1): 164-180.(IF:12.4, Front Cover, ESI)
2020
27. Peng R,† Ji H,† Jin L,† Lin S, Huang Y, Xu K, Yang Q, Sun D,* Wu W,* Macrophage-Based Therapies for Atherosclerosis Management. Journal of Immunology Research, 2020, 2020: 8131754. (IF:3.5)
26. Maruf A, Wang Y, Luo L, Zhong Y, Nurhidayah D, Liu B, Tang D, Rouf M A, Zhang H, Yin Y, Wu W,* Wang G,* Nanoerythrocyte Membrane–Enveloped ROS-Responsive 5-Aminolevulinic Acid Prodrug Nanostructures with Robust Atheroprotection. Particle & Particle Systems Characterization, 2020, 37: 2000021. (IF:2.7)
25. Wijaya A, Maruf A, Wu W,* Wang G,* Recent advances in micro- and nano-bubbles for atherosclerosis applications. Biomaterials Science, 2020, 8: 4920-4939. (IF:5.8)
2019
24. Sun D,†,* Chen J,† Wu W,† Tang J, Luo L, Zhang K, Jin L, Lin S, Gao Y, Yan X, Zhang C, MiR-802 causes nephropathy by suppressing NF-κB-repressing factor in obese mice and human. Journal of Cellular and Molecular Medicine, 2019, 23: 2863-2871. (IF:4.3)
23. Zhong Y, Wang Y, Luo L, Nurhidayah D, Maruf A, Gregersen H, Wu W,* Wang G,* Targeted polyethylenimine/(p53 plasmid) nanocomplexes for potential antitumor applications. Nanotechnology, 2019, 30: 145601. (IF:2.9)
22. Maruf A, Wang Y, Yin T, Huang J, Wang N, Durkan C, Tan Y, Wu W,* Wang G,* Atherosclerosis treatment with stimuli-responsive nanoagents: recent advances and future perspectives. Advanced Healthcare Materials, 2019, 8: 1900036. (IF:10)
21. Wang Y, Zhang K, Qin X, Li T, Qiu J, Yin T, Huang J, McGinty S, Pontrelli G, Ren J, Wang Q, Wu W,* Wang G,* Biomimetic nanotherapies: red blood cell based core–shell structured nanocomplexes for atherosclerosis management. Advanced Science, 2019, 6 (12): 1900172.(IF:14.3, ESI)
20. Sun D,† Chen J,† Wang Y, Ji H, Peng R, Jin L,* Wu W,* Advances in refunctionalization of erythrocyte-based nanomedicine for enhancing cancer-targeted drug delivery. Theranostics, 2019, 9(23): 6885-6900. (IF:12.4)
19. Nurhidayah D, Maruf A, Zhang X, Liao X, Wu W,* Wang G,* Advanced Drug Delivery Systems: Mechanoresponsive Nano-Platforms Applicable in Atherosclerosis Management. Nanomedicine, 2019, 14(23): 3105-3122. (IF:4.7)
2018
18. Luo L,† Wu W,† Sun D,† Dai H, Wang Y, Zhong Y, Wang J, Maruf A, Nurhidayah D, Zhang X, Wang Y, Wang G,* Acid-Activated Melittin for Targeted and Safe Antitumor Therapy. Bioconjugate Chemistry, 2018, 29 (9): 2936-2944. (IF:4)
17. Wang Y, Zhong Y, Luo L, Li X, Yin T, Huang J, Zhang X, Wu W,* Wang G,* Synthesis and characterization of pyrene modified polyethylenimine as a novel fluorescent self-reporter for gene condensation. Materials Chemistry and Physics, 2018, 211: 177-180. (IF:4.3)
16. Wu W,†,* Luo L,† Wang Y,† Wu Q, Dai H, Li J, Durkan C, Wang N, Wang G,* Endogenous pH-Responsive Nanoparticles with programmable size changes for Targeted Tumor Therapy and Imaging Applications. Theranostics, 2018, 8: 3038-3058. (IF:12.4)
2017
15. Wu W, Lin Z, Liu Y, Xu X, Ding C, Li J,* Thermoresponsive hydrogels based on a phosphorylated star-shaped copolymer: mimicking the extracellular matrix for in situ bone repair. Journal of Materials Chemistry B, 2017, 5: 428-434. (IF:6.1)
14. Wu W,† Chen J,† Sun D,†,* Kong X, Xu D, Wang Y, Luo L, Zhang K, Xiao K,* Wang G,* Study on antibacterial performance and biocompatibility of a novel phosphorus-magnesium fiber. Materials Letters, 2017, 209: 562-565. (IF:2.7)
13. Chen J, Wu Q, Luo L, Wang Y, Zhong Y, Dai H, Sun D, Luo M-L, Wu W,* Wang G,* Dual tumor-targeted poly(lactic-co-glycolic acid)-polyethylene glycol–folic acid nanoparticles: a novel biodegradable nanocarrier for secure and efficient antitumor drug delivery. International Journal of Nanomedicine, 2017, 12: 5745-5760. (IF:6.6)
2016
12. Wu W,† Ye C,† Xiao H,† Sun X, Qu W, Li X, Chen M,* Li J,* Hierarchical mesoporous silica nanoparticles for tailorable drug release. International Journal of Pharmaceutics, 2016, 511: 104-109. (IF:5.3)
11. Chen T,† Wu W,† Xiao H,† Chen Y, Chen M, Li J,* Intelligent Drug Delivery System Based on Mesoporous Silica Nanoparticles Coated with an Ultra-pH-Sensitive Gatekeeper and Poly(ethylene glycol). ACS Macro Letters, 2016, 10: 55-58. (IF:5.1)
10. Li S,† Zhao Z,† Wu W,† Ding C, Li J,* Dual pH-responsive micelles with both charge-conversional property and hydrophobic-hydrophilic transition for effective cellular uptake and intracellular drug release. Polymer Chemistry, 2016, 7: 2202-2208. (IF:4.1)
9. Li R-Q,† Wu W,† Song H-Q, Ren Y, Yang M, Li J,* Xu F-J,* Well-defined reducible cationic nanogels based on functionalized low-molecular-weight PGMA for effective pDNA and siRNA delivery. Acta Biomaterialia, 2016, 41: 282-292. (IF:9.4)
8. Li X, Shang H, Wu W,* Li S, Lin Z, Duan J, Xu L, Li J,* Glucose-Responsive Micelles for Controlled Insulin Release Based on Transformation from Amphiphilic to Double Hydrophilic. Journal of Nanoscience and Nanotechnology, 2016, 16: 5457-5463.
2015
7. Wu W, Wang W, Li J,* Star polymers: Advances in biomedical applications. Progress in Polymer Science, 2015, 46:55-85.(IF:26, ESI)
2014
6. Wu W, Zhang Q, Wang J, Chen M, Li S, Lin Z, Li J,* Tumor-targeted aggregation of pH-sensitive nanocarriers for enhanced retention and rapid intracellular drug release. Polymer Chemistry, 2014, 5: 5668-5679. (IF:4.1)
5. Wu W, Wang J, Lin Z, Li X, Li J,* Tumor-acidity activated surface charge-conversion of polymeric nanocarriers for enhanced cell adhesion and targeted drug release. Macromolecular Rapid Communications, 2014, 35: 1679-1684. (IF:4.2)
4. Wu W, Wang W, Li S, Wang J, Zhang Q, Li X, Luo X, Li J,* Physiological pH-triggered morphological transition of amphiphilic block copolymer self-assembly. Journal of Polymer Research, 2014, 21: 494. (IF:2.6)
3. Wu W, Chen M, Wang J, Zhang Q, Li S, Li Z, Li J,* Nanocarriers with dual pH-sensitivity for enhanced tumor cell uptake and rapid intracellular drug release. RSC Advances, 2014, 4: 30780-30783. (IF:3.9)
2. Li S,† Wu W,† Xiu K, Xu F, Li Z,* Li J,* Doxorubicin loaded pH-responsive micelles capable of rapid intracellular drug release for potential tumor therapy. Journal of Biomedical Nanotechnology, 2014, 10: 1480-1489.
2011
1. Wu W, Liu J, Cao S, Tan H, Li J,* Xu F, Zhang X, Drug release behaviors of a pH sensitive semi-interpenetrating polymer network hydrogel composed of poly(vinyl alcohol) and star poly[2-(dimethylamino)ethyl methacrylate]. International Journal of Pharmaceutics, 2011, 416: 65-72. (IF:5.3)
主持科研项目:
1. 国家重点研发计划课题,2022/11-2025/10,260万;
2. 国家自然科学基金面上项目,2022/01-2025/12,58万;
3. 国家自然科学基金面上项目,2020/01-2023/12,57万;
4. 国家自然科学基金青年科学基金项目,2017/01-2019/12,20万;
5. 重庆市科卫联合重点项目,2024/01-2027/01,40万(联合资助);
6. 重庆市自然科学基金面上项目,2021/07-2023/06,10万(联合资助);
7. 重庆市基础科学与前沿技术研究专项一般项目,2017/07-2020/06, 5万;
8. 中央高校基本科研业务费学院科技型专项,2016/01-2017/12,7万;
9. 中央高校基本科研业务费学院科技型专项,2018/01-2019/12,4万;
10. 中国博士后基金特别资助项目,2017/07 -2018/05,15万 ;
11. 中国博士后基金面上项目,2017/01-2018/05,5万;
12. 重庆市博士后基金特别资助项目,2017/01-2017/11,10万;
13. 四川省科技创新苗子工程,2015/07 -2016/06,3万;
14. 重庆大学2018年度科研后备拔尖人才B类,2018/07-2021/07,40万;
15. 中央高校基本科研业务费“基础研究与前沿交叉学科方向培育项目”,2020/01-2021/12,15万;